We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8725:TSEMS&AD Insurance Group Holdings, Inc. Analysis

Data as of 2026-06-12 - not real-time

¥4,597.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Technical momentum is firmly bullish – the short‑term moving average sits above the medium‑term average and the MACD histogram remains positive, while the RSI is in the upper‑mid range but not yet signaling overbought conditions. Price is holding above a solid support zone and remains below a clear resistance ceiling, giving the stock room to advance. The equity exhibits a very low beta, indicating limited sensitivity to broader market swings, and volatility, though noticeable, is manageable for a large insurer.
Fundamentally, the company trades at a price‑earnings multiple well beneath its industry peers, complemented by a strong dividend yield and a modest payout ratio that underscores sustainability. Robust cash generation, a healthy balance sheet with ample cash relative to debt, and a recent record net‑income result bolster confidence. Strategic moves such as the acquisition of a significant stake in Barings signal diversification and growth potential, supporting a medium‑ to long‑term upside thesis.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical alignment with moving averages and MACD
  • Price near recent support with limited upside before resistance
  • Decreasing volume trend suggesting cautious participation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive valuation relative to peers and strong cash flow
  • Sustainable dividend yield enhancing total return
  • Strategic diversification through Barings investment

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistent earnings growth and record net‑income performance
  • Low market beta and defensive insurance franchise
  • Long‑term upside from undervaluation and potential earnings expansion

Key Metrics & Analysis

Financial Health

Revenue Growth18.30%
Profit Margin10.76%
P/E Ratio8.7
ROE17.84%
ROA2.59%
Debt/Equity20.69
P/B Ratio1.4
Op. Cash Flow¥762.6B
Free Cash Flow¥582.6B
Industry P/E16.8

Technical Analysis

TrendBullish
RSI67.6
Support¥4,153.00
Resistance¥4,706.00
MA 20¥4,364.80
MA 50¥4,201.86
MA 200¥3,810.38
MACDBullish
VolumeDecreasing
Fear & Greed Index88.79

Valuation

Fair Value¥11,938.97
Target Price¥4,480.91
Upside/Downside-2.53%
GradeUndervalued
TypeBlend
Dividend Yield3.08%

Risk Assessment

Beta0.30
Volatility28.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.